Timothy I. Johnson

Cambridge, ENG CB20XZ, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Corrigendum to "Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells" [Metabol. Eng. 45 (2018) 149-157].

Corrigendum to "Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells" [Metabol. Eng. 45 (2018) 149-157].

Journal: Metabolic engineering

Published: January 20, 2024

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types.

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 15, 2023

Quantifying cell cycle-dependent drug sensitivities in cancer using a high throughput synchronisation and screening approach.

Quantifying cell cycle-dependent drug sensitivities in cancer using a high throughput synchronisation and screening approach.

Journal: EBioMedicine

Published: January 11, 2021

CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.

CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 31, 2020

Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models.

Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models.

Journal: British journal of cancer

Published: March 25, 2020

The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression.

The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression.

Journal: Molecular cancer therapeutics

Published: January 08, 2018

Fumarate hydratase loss promotes mitotic entry in the presence of DNA damage after ionising radiation.

Fumarate hydratase loss promotes mitotic entry in the presence of DNA damage after ionising radiation.

Journal: Cell death & disease

Published: December 13, 2017

Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells.

Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells.

Journal: Metabolic engineering

Published: September 05, 2017

NEFM (Neurofilament Medium) Polypeptide, a Marker for Zona Glomerulosa Cells in Human Adrenal, Inhibits D1R (Dopamine D1 Receptor)-Mediated Secretion of Aldosterone.

NEFM (Neurofilament Medium) Polypeptide, a Marker for Zona Glomerulosa Cells in Human Adrenal, Inhibits D1R (Dopamine D1 Receptor)-Mediated Secretion of Aldosterone.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: February 11, 2017

Physiological and Pathological Roles in Human Adrenal of the Glomeruli-Defining Matrix Protein NPNT (Nephronectin).

Physiological and Pathological Roles in Human Adrenal of the Glomeruli-Defining Matrix Protein NPNT (Nephronectin).

Journal: Hypertension (Dallas, Tex. : 1979)

Published: January 26, 2017

Corrigendum: Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition.

Corrigendum: Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition.

Journal: Nature

Published: November 04, 2016

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition.

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition.

Journal: Nature

Published: June 16, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026